Research & Innovation on Probiotics
ProBion is based on science and demonstrated evidence and we follow rigorous scientific process. ProBion tablet disintegration profile has been verified according to the European Pharmacopoeia. This provides common quality standards throughout the pharmaceutical industry in Europe to control the quality of medicines, and the substances used to manufacture them.
Colon Cancer Studies
ProBion Clinica was used as the preferred regimen during the recent colon cancer clinical trial published in the British Medical Journal (BMJ Open Gastro) July 2017.
Results: “ProBion clinica given to colon cancer patients reduces more than 90% of cancer related microbes”.
Innovative production technique efficiently delivers, feeds and protects vigorous and non-damaged bacteria in the gastrointestinal tract for extended periods of time.